In this issue: Heart Research Centers International Launches SMO, Phoenix International Divests its Pharmacology Unit in France, Quarterly Reports, Innovative Clinical Solutions Delisted from Nasdaq National Market, PharmaNetics is Preferred Provider for Duke Clinical Research Institute, Feds Say COMIRB Can Re-open More Trials, The CenterWatch Index, Industry Briefs, Drug Pipeline News, Trial Results and Personnel